Ultraviolet Blood Irradiation: New Hope for Chronic COVID
By Thomas Levy, MD, JD
Ultraviolet (UV) irradiation of the blood is a very old but highly effective therapy for a wide range of infections and medical conditions. Early to moderately advanced infectious diseases were shown to be curable nearly 100% of the time. Both bacterial and viral infections have been readily resolved. Wound healing is strongly enhanced, and many different diseases and chronic medical conditions have also been shown to respond very well.
Just as important as the ability of UV irradiation to rapidly resolve infections is its ability to inactivate toxins. Such toxins include those of diphtheria and tetanus, as well as of snake venom. Nearly any toxin comprised of protein can be inactivated by UV irradiation, as it is able to denature (breakdown) proteins as well as cause them to “unfold,” which partially or completely blocks their function by changing their three-dimensional configuration. Also, once partially denatured, many proteins can then be metabolized completely and eliminated from the body.
The toxic agent that is considered to be the primary reason for most of the morbidity and mortality seen in chronic COVID patients and some patients post-vaccination is the spike protein. The spike protein is that part of the COVID pathogen that attaches to cellular receptors (ACE2) throughout the body and permits the entry of the entire pathogen into those cells. The ACE2 receptors are so widespread that there appear to be no tissues or organs in the body that are completely spared from the infectious and toxic impact of the spike protein.
The continued presence of the spike protein (Persistent Spike Protein [PSP] syndrome) in patients who have never fully recovered from COVID (chronic COVID) is becoming increasingly common and resulting in increased illness and early death in millions of people around the world. However, PSP syndrome is also commonly appearing in post-vaccination patients regardless of whether the COVID pathogen was ever contracted. This should not come as a surprise, as the purpose of the vaccine is to use mRNA to enter the genome to produce spike protein inside the body, purportedly to stimulate an immune response to the entire spike protein-containing COVID pathogen. However, it is now well-documented that many people continue to produce the spike protein long after the vaccination, resulting in the PSP syndrome. And when the vaccination is given to someone who has also contracted COVID at some point in time, it only results in a higher amount of circulating spike protein in the body. Until compelling data indicates a clear-cut benefit to patient health and longevity, consideration should be given to avoiding any of the booster shots that are designed to stimulate further production and presence of spike protein in the body.
Currently, blood testing for the spike protein is not readily available except for research laboratories. However, the PSP syndrome is closely linked to elevations of D-Dimer in the blood. D-Dimer is a product that results from the breakdown and dissolution of blood clots in the body. When there is an abnormal increase in blood clotting, there is a corresponding increase in the D-Dimer breakdown product. As it is a readily available blood test, D-Dimer testing is an excellent way to better monitor how well a chronic COVID or post-vaccination patient is responding to whatever therapies are being administered. Generally, symptom relief closely parallels the lowering or normalization of an elevated D-Dimer level.
Bio-oxidative therapies, such as vitamin C, hydrogen peroxide, ozone, hyperbaric oxygen, and ultraviolet light have all been shown to be highly effective in the inactivation and/or killing of nearly all pathogens. The COVID infective agent has been shown to be very susceptible to these therapies as well.
Very recent clinical research now shows the UV light irradiation (wavelength 254 nm) can promptly reduce and even normalize D-Dimer levels in chronic COVID patients. As expected, the normalization of the D-Dimer level is typically also accompanied by dramatic symptom relief. Currently, the D-Dimer level laboratory reference range is 0 to 500 ng/cc, or 0 to 0.5 mg/L. While UV irradiation and other effective therapies should be continued as long as the D-Dimer level is greater than 500, it is also reasonable to continue them long enough to see if the level can be dropped even further, to 300 or less, assuring a more comfortable degree of normalcy and eradication of the spike protein.
Because of the nature of the spike protein and its ability to be generated inside the cells, especially after vaccination, it is not possible at this time to regard a normalization of D-Dimer and resolution of COVID symptoms as being a definitive cure with a complete elimination of spike protein from the body. However, the Ultraviolet Blood Irradiation Protocol as established at the Riordan Clinic for some years now can be repeated as needed if symptoms recur and D-Dimer levels again rise.
Proteolytic enzyme therapy is recommended by many clinicians now to minimize or eliminate circulating spike protein. These include nattokinase, lumbrokinase, serrapeptase, and bromelain taken with N-acetylcysteine. These agents have multiple beneficial effects on health, and one or more of them should still be taken when a D-Dimer level has normalized with UV irradiation and/or other therapies. As noted earlier, UV irradiation clearly can breakdown the spike protein present in the blood. However, even spike protein fragments have been shown to be potent inflammatory and disease-causing agents. Because of this, oral proteolytic enzyme administration is still a good idea to help further breakdown any remaining protein fragments into their constituent amino acids or to a degree where phagocytic white blood cells and the immune system can then clear them out completely.
Ozone therapies and intravenous vitamin C administrations are also very important in reaching a complete clinical recovery from PSP syndrome, both of which are available at the Riordan Clinic.
Rowen R (1996) Ultraviolet blood irradiation therapy (photo-oxidation), the cure that time forgot. International Journal of Biosocial and Medical Research 14:115-132l https://www.drmichaelschoenwalder.com/wp-content/uploads/2020/12/Ultraviolet-Blood-Irradiation-Therapy-Photo-Oxidation-The-Cure-That-Time-Forgot.pdf
Heilingloh C, Aufderhorst U, Schipper L et al. (2020) Susceptibility of SARS-CoV-2 to UV irradiation. American Journal of Infection Control 48:1273-1275. PMID: 32763344
Reed N (2010) The history of ultraviolet germicidal irradiation for air disinfection. Public Health Reports 125:15-27. PMID: 20402193
evy T (2023) http://orthomolecular.org/resources/omns/v19n15.shtml
Parry P, Lefringhausen A, Turni C et al. (2023) “Spikeopathy”: COVID-19 spike protein is pathogenic, from both virus and vaccine mRNA. Biomedicines 11:2287. PMID: 37626783
Cao S, Song Z, Rong J et al. (2023) Spike protein fragments promote Alzheimer’s amyloidogenesis. ACS Applied Materials & Interfaces 15: 40317-40329. PMID: 37585091